Skip to main content

Table 3 Subject characteristics

From: Effect of catgut implantation at acupoints for the treatment of allergic rhinitis: a randomized, sham-controlled trial

 

Group A (Active treatment group)

Group B (Sham-controlled group)

Statistics

P value

Age (years)

36.112 ± 11.495

38.083 ± 12.106

T = 1.047

0.297

Gendera (males/female)

29/35

36/28

x2=1.532

0.216

Weight (kg)

60.391 ± 9.407

59.817 ± 8.697

t = 0.177

0.860

Height (cm)b

166.031 ± 6.575

164.752 ± 6.731

U = 1854.5

0.356

Pulse (beats/min)b

75.828 ± 6.870

77.297 ± 6.004

U = 1788.000

0.214

EO (109/L)b

0.201 ± 0.132

0.195 ± 0.139

U = 1952.000

0.647

AST (U/L)

28.141 ± 7.322

29.672 ± 9.952

t = −0.991

0.324

ALT (U/L)

21.656 ± 6.393

23.125 ± 6.646

t = −1.274

0.205

BUN (mmol/L)b

4.572 ± 1.540

4.988 ± 1.325

U = 1804.000

0.245

Crea (μmol/L)b

53.367 ± 11.068

56.094 ± 9.018

U = 1726.520

0.125

RQLQ score

83.933 ± 10.076

88.801 ± 8.872

t = −1.405

0.171

VAS scoreb

7.036 ± 1.839

6.648 ± 1.379

U = 1739.500

0.136

TCM syndrome typea (number of patients)

  

x2=1.030

0.794

 Insufficiency of the Spleen-qia

25

23

 Insufficiency of the Lung-qia

23

26

 Insufficiency of the Kidney-yanga

9

6

 Retention of the Pathogenic Heat of the Lunga

7

9

  1. RQLQ Rhinitis Quality of Life Questionnaire, VAS Visual Analogue Scale
  2. For each variable except gender and TCM syndrome type, the values are expressed as the means ± SD
  3. aChi-square test
  4. bWilcoxon rank-sum test for the non-normally distributed data
  5. The categories without aor bwere analyzed with t test